From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Abstract
Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence approaches have been applied to guide traditional experiments, which are expensive and time-consuming. Over the past several decades, machine-learning tools, such as quantitative structure-activity relationship (QSAR) modeling, were developed that can identify potential biological active molecules from millions of candidate compounds quickly and cheaply. However, when drug discovery moved into the era of 'big' data, machine learning approaches evolved into deep learning approaches, which are a more powerful and efficient way to deal with the massive amounts of data generated from modern drug discovery approaches. Here, we summarize the history of machine learning and provide insight into recently developed deep learning approaches and their applications in rational drug discovery. We suggest that this evolution of machine intelligence now provides a guide for early-stage drug design and discovery in the current big data era.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Machine learning can be used to streamline various tasks in drug discovery, including drug compound property and activity prediction, de novo design of drug compounds, drug-receptor interactions, and drug reaction prediction.
“There are various tasks in the drug discovery process where machine learning can be used to streamline the tasks. This includes drug compound property and activity prediction, de novo design of drug compounds, drug–receptor interactions, and drug reaction prediction [16].”
From The rise of artificial intelligence in healthcare applications (2020) · cites this paper as [16]
QSAR modeling methods, such as linear discriminant analysis (LDA), support vector machines (SVMs), random forest (RF), and decision trees, have been used to identify prospective drug candidates and have evolved into AI-based QSAR approaches can use that to speed up QSAR analysis.
“QSAR modeling methods, such as linear discriminant analysis (LDA), support vector machines (SVMs), random forest (RF), and decision trees, have been used to identify prospective drug candidates and have evolved into AI-based QSAR approaches can use that to speed up QSAR analysis”
From Blockchain and Artificial Intelligence Technology in E-Health (2021) · cites this paper as Zhang 2017 & Jain 2015
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538 · see citing works
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126 · see citing works
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892 · see citing works
Wu, Y., & Vapnik, V. N. (1999) · Technometrics · doi:10.2307/1271368 · Cited by 27,236 · see citing works
Deep learning in neural networks: an overview
Schmidhuber, J. (2015) · Neural Networks · doi:10.1016/j.neunet.2014.09.003 · Cited by 18,570 · see citing works
Eigenfaces vs. Fisherfaces: recognition using class specific linear projection
Belhumeur, P. N., Hespanha, J. P., & Kriegman, D. (1997) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/34.598228 · Cited by 11,776 · see citing works
An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression
Altman, N. (1992) · The American Statistician · doi:10.1080/00031305.1992.10475879 · Cited by 5,721 · see citing works
Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning
Alipanahi, B., Delong, A., Weirauch, M. T., & Frey, B. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3300 · Cited by 2,873 · see citing works
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,344 · see citing works
Big data deep learning: Challenges and perspectives
Chen, X.-W., & Lin, X. (2014) · IEEE Access · doi:10.1109/access.2014.2325029 · Cited by 1,255 · see citing works
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159 · see citing works
Eigenfaces vs. Fisherfaces: Recognition using class specific linear projection
Belhumeur, P. N., Hespanha, J. P., & Kriegman, D. (1996) · Lecture notes in computer science · doi:10.1007/bfb0015522 · Cited by 982 · see citing works
Machine-learning approaches in drug discovery: methods and applications
Lavecchia, A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.012 · Cited by 801 · see citing works
On Outliers and Activity CliffsWhy QSAR Often Disappoints
Maggiora, G. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060117s · Cited by 728 · see citing works
Applications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701 · see citing works
Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610 · see citing works
Deep-Learning-Based Drug–Target Interaction Prediction
Wen, M., Zhang, Z., Niu, S., Sha, H., Yang, R., Yun, Y., & Lü, H. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00618 · Cited by 583 · see citing works
Recognizing Pitfalls in Virtual Screening: A Critical Review
Scior, T., Bender, A., Tresadern, G., Medina-Franco, J. L., Martínez-Mayorga, K., Langer, T., Cuanalo-Contreras, K., & Agrafiotis, D. K. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200528d · Cited by 438 · see citing works
Boosting docking-based virtual screening with deep learning.
Pereira, J. C., Caffarena, E. R., & dos Santos, C. N. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00355 · Cited by 395 · see citing works
Sarker, D., Ang, J. E., Baird, R. D., Kristeleit, R. S., Shah, K. J., Moreno, V., Clarke, P. A., Raynaud, F. I., Levy, G. G., Ware, J. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0947 · Cited by 361 · see citing works
Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350 · see citing works
Quantitative Structure−Activity Relationship Modeling of Rat Acute Toxicity by Oral Exposure
Zhu, H., Martin, T. M., Ye, L., Sedykh, A., Young, D. M., & Tropsha, A. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900189p · Cited by 287 · see citing works
Self-citationIntegrative data analysis of multi-platform cancer data with a multimodal deep learning approach
Liang, M., Li, Z., Chen, T., & Zeng, J. (2015) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2014.2377729 · Cited by 231 · see citing works
Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network
Hughes, T. B., Miller, G. P., & Swamidass, S. J. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00131 · Cited by 203 · see citing works
QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds
Zhang, L., Zhu, H., Oprea, T. I., Golbraikh, A., & Tropsha, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9609-0 · Cited by 201 · see citing works
Self-citationThe Trouble with QSAR (or How I Learned To Stop Worrying and Embrace Fallacy)
Johnson, S. R. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700332k · Cited by 183 · see citing works
DeeperBind: Enhancing prediction of sequence specificities of DNA binding proteins
Hassanzadeh, H. R., & Wang, M. D. (2016) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2016.7822515 · Cited by 148 · see citing works
Mayer, P., & Reichenberg, F. (2006) · Environmental Toxicology and Chemistry · doi:10.1897/06-142r.1 · Cited by 140 · see citing works
Kim, M. T., Sedykh, A., Chakravarti, S., Saiakhov, R., & Zhu, H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1222-1 · Cited by 127 · see citing works
Self-citationQuantitative structure–activity relationship: promising advances in drug discovery platforms
Wang, T., Wu, M., Lin, J., & Yang, L.-R. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1083006 · Cited by 124 · see citing works
Ratni, H., Karp, G. M., Weetall, M. L., Naryshkin, N. A., Paushkin, S. V., Chen, K. S., McCarthy, K. D., Qi, H., Turpoff, A., Woll, M. G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00459 · Cited by 119 · see citing works
Newby, D., Freitas, A. A., & Ghafourian, T. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.006 · Cited by 103 · see citing works
Interaction prediction in structure-based virtual screening using deep learning
Gonczarek, A., Tomczak, J. M., Zaręba, S., Kaczmar-Michalska, J., Dąbrowski, P., & Walczak, M. (2017) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2017.09.007 · Cited by 103 · see citing works
Wang, W., Kim, M. T., Sedykh, A., & Zhu, H. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1687-1 · Cited by 93 · see citing works
Self-citationWalton, M. I., Eve, P. D., Hayes, A., Valenti, M. R., Brandon, A. K. D. H., Box, G., Hallsworth, A., Smith, E. L., Boxall, K. J., Lainchbury, M. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1322 · Cited by 92 · see citing works
QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest
Singh, H., Singh, S., Singla, D., Agarwal, S. M., & Raghava, G. P. S. (2015) · Biology Direct · doi:10.1186/s13062-015-0046-9 · Cited by 83 · see citing works
Wang, Y., Guo, Y., Kuang, Q., Pu, X., Ji, Y., Zhang, Z., & Li, M. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9827-y · Cited by 69 · see citing works
Danishuddin, M., & Khan, A. U. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.019 · Cited by 58 · see citing works
Identification of human drug targets using machine-learning algorithms
Kumari, P., Nath, A., & Chaube, R. (2014) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2014.11.008 · Cited by 54 · see citing works
Predicting Chemical Ocular Toxicity Using a Combinatorial QSAR Approach
Solimeo, R., Zhang, J., Kim, M. T., Sedykh, A., & Zhu, H. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300393v · Cited by 54 · see citing works
Self-citationImplementation of an ADME enabling selection and visualization tool for drug discovery
Stoner, C. L., Gifford, E., Stankovic, C. J., Lepsy, C. S., Brodfuehrer, J., Prasad, J. V. N. V., & Surendran, N. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20020 · Cited by 50 · see citing works
Generating Focussed Molecule Libraries for Drug Discovery with Recurrent Neural NetworksPreprint
Segler, M., Kogej, T., Tyrchan, C., & Waller, M. P. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1701.01329 · Cited by 49 · see citing works
Mistry, P., Neagu, D. C., Trundle, P. R., & Vessey, J. D. (2015) · Soft Computing · doi:10.1007/s00500-015-1925-9 · Cited by 44 · see citing works
Zhang, N., Zhang, X., Zhu, J., Turpoff, A., Chen, G., Morrill, C., Huang, S., Lennox, W., Kakarla, R., Liu, R., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401621g · Cited by 44 · see citing works
In silico de novo design of novel NNRTIs: a bio-molecular modelling approach
Jain, N., Gupta, S., Sapre, N., & Sapre, N. S. (2015) · RSC Advances · doi:10.1039/c4ra15478a · Cited by 35 · see citing works
QuBiLs-MAS method in early drug discovery and rational drug identification of antifungal agents
Marrero, R. M., Marrero‐Ponce, Y., Barigye, S. J., Díaz, Y. E., Barrios, R. L. A., Casañola‐Martín, G. M., Bernal, M. G., Torrens, F., & Pérez‐Giménez, F. (2015) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2015.1104517 · Cited by 31 · see citing works
Jaradat, N. J., Khanfar, M. A., Habash, M., & Taha, M. O. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9848-1 · Cited by 30 · see citing works
Sprague, B., Shi, Q., Kim, M. T., Zhang, L., Sedykh, A., Ichiishi, E., Tokuda, H., Lee, K., & Zhu, H. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9748-9 · Cited by 26 · see citing works
Self-citationGupta, S., Basant, N., & Singh, K. P. (2015) · Ecotoxicology · doi:10.1007/s10646-015-1431-y · Cited by 25 · see citing works
Weidlich, I. E., Filippov, I. V., Brown, J. A., Kaushik‐Basu, N., Krishnan, R., Nicklaus, M. C., & Thorpe, I. F. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.032 · Cited by 25 · see citing works
DeeperBind: Enhancing Prediction of Sequence Specificities of DNA Binding ProteinsPreprint
Hassanzadeh, H. R., & Wang, M. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/099754 · Cited by 25 · see citing works
3D Pharmacophoric Similarity improves Multi Adverse Drug Event Identification in Pharmacovigilance
Vilar, S., Tatonetti, N. P., & Hripcsak, G. M. (2015) · Scientific Reports · doi:10.1038/srep08809 · Cited by 23 · see citing works
Vilar, S., Lorberbaum, T., Hripcsak, G. M., & Tatonetti, N. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129974 · Cited by 22 · see citing works
Zhang, T., Nie, S., Liu, B., Yu, Y., Zhang, Y., & Liu, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119598 · Cited by 19 · see citing works
MCASE study of the multidrug resistance reversal activity of propafenone analogs
Klopman, G., Zhu, H., Ecker, G. F., & Chiba, P. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1026124505322 · Cited by 17 · see citing works
Self-citationPoorinmohammad, N., Mohabatkar, H., Behbahani, M., & Biria, D. (2014) · Journal of Peptide Science · doi:10.1002/psc.2712 · Cited by 17 · see citing works
3D Deep Learning for Biological Function Prediction from Physical Fields
Golkov, V., Skwark, M. J., Mirchev, A., Dikov, G., Geanes, A. R., Mendenhall, J., Meiler, J., & Cremers, D. (2020) · International Conference on 3D Vision (3DV) · doi:10.1109/3dv50981.2020.00103 · Cited by 15 · see citing works
DeepCCI: End-to-end Deep Learning for Chemical-Chemical Interaction PredictionPreprint
Kwon, S., & Yoon, S. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1704.08432 · Cited by 14 · see citing works
Using Deep Learning for Compound Selectivity Prediction
Zhang, R., Li, J., Lu, J., Hu, R., Yuan, Y., & Zhao, Z. (2016) · Current Computer - Aided Drug Design · doi:10.2174/1573409912666160219113250 · Cited by 13 · see citing works
Flagged first, then by citations
1 of the 60 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695 · see citing works
The rise of artificial intelligence in healthcare applications
Bohr, A., & Memarzadeh, K. (2020) · Artificial Intelligence in Healthcare · doi:10.1016/b978-0-12-818438-7.00002-2 · Cited by 1,636 · see citing works
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473 · see citing works
“Thus, the biggest question that arises in front of pharmaceutical companies is managing the cost and speed of the process [5].”
BackgroundNatural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P. P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,268 · see citing works
Drug discovery with explainable artificial intelligence
Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063 · see citing works
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X. Y., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,045 · see citing works
Next-Generation Machine Learning for Biological Networks
Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C., & Collins, J. J. (2018) · Cell · doi:10.1016/j.cell.2018.05.015 · Cited by 974 · see citing works
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910 · see citing works
ADMET modeling approaches in drug discovery
Ferreira, L. L. G., & Andricopulo, A. D. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.015 · Cited by 842 · see citing works
Development and evaluation of a deep learning model for protein–ligand binding affinity prediction
Stepniewska-Dziubinska, M. M., Zielenkiewicz, P., & Siedlecki, P. S. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty374 · Cited by 665 · see citing works
Jiang, D., Wu, Z., Hsieh, C.-Y., Chen, G., Liao, B., Wang, Z., Shen, C., Cao, D., Wu, J., & Hou, T. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-020-00479-8 · Cited by 664 · see citing works
Manickam, P., Mariappan, S. A., Murugesan, S. M., Hansda, S., Kaushik, A. K., Shinde, R. B., & Thipperudraswamy, S. P. (2022) · Biosensors · doi:10.3390/bios12080562 · Cited by 695 · see citing works
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 631 · see citing works
A drug-likeness toolbox facilitates ADMET study in drug discovery
Jia, C., Li, J., Hao, G., & Yang, G. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.10.014 · Cited by 556 · see citing works
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464 · see citing works
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455 · see citing works
Self-citationResearch and application of machine learning for additive manufacturing
Qin, J., Hu, F., Liu, Y., Witherell, P., Wang, C. C. L., Rosen, D. W., Simpson, T. W., Lu, Y., & Tang, Q. (2022) · Additive Manufacturing · doi:10.1016/j.addma.2022.102691 · Cited by 391 · see citing works
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Lane, E., Asadulaev, A., Ivanenkov, Y. A., Aladinskiy, V., Sánchez-Lengeling, B., Aspuru‐Guzik, A., & Zhavoronkov, A. A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 381 · see citing works
Artificial Intelligence in Drug Design
Heßler, G., & Baringhaus, K. H. (2018) · Molecules · doi:10.3390/molecules23102520 · Cited by 387 · see citing works
Autonomous Discovery in the Chemical Sciences Part I: Progress
Coley, C. W., Eyke, N. S., & Jensen, K. F. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909987 · Cited by 365 · see citing works
Potential of quantum computing for drug discovery
Cao, Y., Romero, J., & Aspuru-Guzik, A. (2018) · IBM Journal of Research and Development · doi:10.1147/jrd.2018.2888987 · Cited by 357 · see citing works
Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis
Niazi, S. K., & Mariam, Z. (2023) · Pharmaceuticals · doi:10.3390/ph17010022 · Cited by 361 · see citing works
Park, S.-O., Jeong, H., Park, J., Bae, J., & Choi, S. (2022) · Nature Communications · doi:10.1038/s41467-022-30539-6 · Cited by 331 · see citing works
“All experiments are conducted in a 20 × 20 gradual TiO x memristor cross-bar array, where a single cell size is 5 × 5 µm 2 .”
MethodTackling climate change with machine learning
Rolnick, D., Donti, P. L., Kaack, L. H., Kochanski, K., Lacoste, A., Sankaran, K., Ross, A. S., Milojevic-Dupont, N., Jaques, N., Waldman-Brown, A., et al. (2023) · ACM Computing Surveys · doi:10.1145/3485128 · Cited by 336 · see citing works
Guedes, I. A., Pereira, F. S. S., & Dardenne, L. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01089 · Cited by 331 · see citing works
The significance of artificial intelligence in drug delivery system design
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.001 · Cited by 307 · see citing works
Integrated phenology and climate in rice yields prediction using machine learning methods
Guo, Y.-H., Fu, Y.-S. H., Hao, F., Zhang, X., Wu, W.-X., Jin, X.-L., Bryant, C. R., & Senthilnath, J. (2021) · Ecological Indicators · doi:10.1016/j.ecolind.2020.106935 · Cited by 258 · see citing works
Blockchain and Artificial Intelligence Technology in E-Health
Tagde, P., Tagde, S., Bhattacharya, T., Tagde, P., Chopra, H., Akter, R., Kaushik, D., & Rahman, M. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16223-0 · Cited by 281 · see citing works
Artificial Intelligence in Pharmaceutical and Healthcare Research
Bhattamisra, S. K., Banerjee, P., Gupta, P., Mayuren, J., Patra, S., & Candasamy, M. (2023) · Big Data and Cognitive Computing · doi:10.3390/bdcc7010010 · Cited by 283 · see citing works
CADD, AI and ML in drug discovery: A comprehensive review
Vemula, D., Jayasurya, P., Sushmitha, V., Kumar, Y. N., & Bhandari, V. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106324 · Cited by 254 · see citing works
From machine learning to deep learning: Advances in scoring functions for protein–ligand docking
Shen, C., Ding, J., Wang, Z., Cao, D., Ding, X., & Hou, T. (2019) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1429 · Cited by 245 · see citing works
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
Zhao, L., Ciallella, H. L., Aleksunes, L. M., & Zhu, H. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.005 · Cited by 237 · see citing works
Self-citationMachine learning applications in drug development
Réda, C., Kaufmann, E., & Delahaye‐Duriez, A. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.006 · Cited by 224 · see citing works
Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks
Ghasemi, F., Mehridehnavi, A., Pérez-Garrido, A., & Pérez‐Sánchez, H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.06.016 · Cited by 224 · see citing works
The prospects of quantum computing in computational molecular biology
Outeiral, C., Strahm, M., Shi, J., Morris, G. M., Benjamin, S. C., & Deane, C. M. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1481 · Cited by 232 · see citing works
Game theory interpretation of digital soil mapping convolutional neural networks
Padarian, J., McBratney, A. B., & Minasny, B. (2020) · SOIL · doi:10.5194/soil-6-389-2020 · Cited by 182 · see citing works
Deep learning models in genomics; are we there yet?
Koumakis, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.017 · Cited by 177 · see citing works
Deep learning tools for advancing drug discovery and development
Nag, S., Baidya, A. T. K., Mandal, A., Mathew, A. T., Das, B., Devi, B., & Kumar, R. (2022) · 3 Biotech · doi:10.1007/s13205-022-03165-8 · Cited by 182 · see citing works
Sevakula, R. K., Au-Yeung, W.-T. M., Singh, J. P., Heist, E. K., Isselbacher, E. M., & Armoundas, A. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013924 · Cited by 177 · see citing works
Machine‐learning scoring functions for structure‐based virtual screening
Li, H., Sze, K., Lü, G., & Ballester, P. J. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1478 · Cited by 167 · see citing works
Aminpour, M., Montemagno, C. D., & Tuszyński, J. A. (2019) · Molecules · doi:10.3390/molecules24091693 · Cited by 165 · see citing works
Bai, Q., Liu, S., Tian, Y., Xu, T., Banegas‐Luna, A. J., Pérez‐Sánchez, H., Huang, J., Liu, H., & Yao, X. (2022) · WIREs Computational Molecular Science · doi:10.1002/wcms.1581 · Cited by 156 · see citing works
Toxicity prediction based on artificial intelligence: A multidisciplinary overview
Pérez Santín, E., Rodríguez Solana, R., González García, M., García Suárez, M. D. M., Blanco Díaz, G. D., Cima Cabal, M. D., Moreno Rojas, J. M., & López Sánchez, J. I. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1516 · Cited by 153 · see citing works
Application of Computational Biology and Artificial Intelligence in Drug Design
Zhang, Y., Luo, M., Wu, P., Wu, S., Lee, T.-Y., & Bai, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113568 · Cited by 160 · see citing works
Yang, S., & Kar, S. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100011 · Cited by 160 · see citing works
Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective
Sufyan, M., Shokat, Z., & Ashfaq, U. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107356 · Cited by 149 · see citing works
Mrksich, K., Padilla, M. S., & Mitchell, M. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115446 · Cited by 155 · see citing works
Computational Drug Design Methods—Current and Future Perspectives
Prieto-Martínez, F. D., López‐López, E., Juárez‐Mercado, K. E., & Medina‐Franco, J. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00002-x · Cited by 152 · see citing works
Machine‐learning scoring functions for structure‐based drug lead optimization
Li, H., Sze, K., Lü, G., & Ballester, P. J. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1465 · Cited by 147 · see citing works
Morphological, Physiological and Molecular Markers for Salt-Stressed Plants
Soltabayeva, A., Ongaltay, A., Omondi, J. O., & Srivastava, S. (2021) · Plants · doi:10.3390/plants10020243 · Cited by 148 · see citing works
Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery
Tripathi, M. K., Nath, A., Singh, T. P., Ethayathulla, A. S., & Kaur, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10256-w · Cited by 146 · see citing works
Advances in Artificial Intelligence (AI)-assisted approaches in drug screening
Singh, S., Gupta, H., Sharma, P., & Sahi, S. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100039 · Cited by 144 · see citing works
Niazi, S. K. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s424991 · Cited by 146 · see citing works
Recent applications of machine learning in medicinal chemistry
Panteleev, J., Gao, H., & Jia, L. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.06.046 · Cited by 129 · see citing works
A Distinctive Explainable Machine Learning Framework for Detection of Polycystic Ovary Syndrome
Khanna, V. V., Chadaga, K., Sampathila, N., Prabhu, S., Bhandage, V. A., & Hegde, G. K. (2023) · Applied System Innovation · doi:10.3390/asi6020032 · Cited by 138 · see citing works
In silico approaches and tools for the prediction of drug metabolism and fate: A review
Kazmi, S. R., Ren, J., Yu, M., Jung, C., & Na, D. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.01.008 · Cited by 125 · see citing works
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace
Singh, N., Chaput, L., & Villoutreix, B. O. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa034 · Cited by 123 · see citing works
CIoT-Net: a scalable cognitive IoT based smart city network architecture
Park, J.-H., Salim, M. M., Jo, J. H., Sicato, J. C. S., Rathore, S., & Park, J. H. (2019) · Human-centric Computing and Information Sciences · doi:10.1186/s13673-019-0190-9 · Cited by 121 · see citing works
Drug–Membrane Permeability across Chemical Space
Menichetti, R., Kanekal, K. H., & Bereau, T. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00718 · Cited by 2 · see citing works
A review on compound-protein interaction prediction methods: Data, format, representation and model
Lim, S., Lu, Y., Cho, C. Y., Sung, I., Kim, J.-W., Kim, Y., Park, S., & Kim, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.004 · Cited by 116 · see citing works
Transfer and Multi-task Learning in QSAR Modeling: Advances and Challenges
Simões, R. D. S., Maltarollo, V. G., Oliveira, P. R., & Honório, K. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00074 · Cited by 116 · see citing works
Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery
Lane, T. R., Russo, D. P., Zorn, K. M., Clark, A. M., Korotcov, A. V., Tkachenko, V., Reynolds, R. C., Perryman, A. L., Freundlich, J. S., & Ekins, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00083 · Cited by 117 · see citing works
Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications
Dhudum, R., Ganeshpurkar, A., & Pawar, A. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010009 · Cited by 127 · see citing works
Automated Experimentation Powers Data Science in Chemistry
Shi, Y. J., Prieto, P. L., Zepel, T., Grunert, S., & Hein, J. E. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00736 · Cited by 118 · see citing works
Madani, M., Behzadi, M. M., & Nabavi, S. (2022) · Cancers · doi:10.3390/cancers14215334 · Cited by 122 · see citing works
Machine Learning and Big Data Provide Crucial Insight for Future Biomaterials Discovery and Research
Kerner, J., Dogan, A. B., & von Recum, H. A. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.053 · Cited by 106 · see citing works
Applications of deep learning for the analysis of medical data
Jang, H., & Cho, K. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01162-9 · Cited by 105 · see citing works
Nayarisseri, A., Khandelwal, R., Tanwar, P., Madhavi, M., Sharma, D., Thakur, G., Speck‐Planche, A., & Singh, S. K. (2021) · Current Drug Targets · doi:10.2174/1389450122999210104205732 · Cited by 105 · see citing works
Srinivasan, M., Venugopal, A., Venkatesan, L., & Kumar, R. (2024) · JMIR Nursing · doi:10.2196/52105 · Cited by 96 · see citing works
Artificial Intelligence in Materials Modeling and Design
Huang, J., Liew, J. X., Ademiloye, A. S., & Liew, K. M. (2020) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-020-09506-1 · Cited by 98 · see citing works
An Analysis of QSAR Research Based on Machine Learning Concepts
Keyvanpour, M. R., & Shirzad, M. B. (2020) · Current Drug Discovery Technologies · doi:10.2174/1570163817666200316104404 · Cited by 96 · see citing works
Revealing Drug-Target Interactions with Computational Models and Algorithms
Zhou, L., Li, Z., Yang, J., Tian, G., Liu, F., Wen, H., Li, P., Chen, M., Xiang, J., & Peng, L. (2019) · Molecules · doi:10.3390/molecules24091714 · Cited by 95 · see citing works
Harnessing machine learning for development of microbiome therapeutics
McCoubrey, L. E., Elbadawi, M., Orlu, M., Gaisford, S., & Basit, A. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1872323 · Cited by 94 · see citing works
Ali, R. S. A. E., Meng, J., Khan, M. E. I., & Jiang, X. (2024) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2024.100049 · Cited by 98 · see citing works
Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning
Miao, R., Xia, L.-Y., Chen, H.-H., Huang, H.-H., & Liang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-44773-4 · Cited by 91 · see citing works
Gowd, A. K., Agarwalla, A., Amin, N. H., Romeo, A. A., Nicholson, G. P., Verma, N. N., & Liu, J. N. (2019) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2019.05.017 · Cited by 91 · see citing works
Khanam, M. M., Uddin, M. K., & Kazi, J. U. (2025) · Frontiers in Environmental Science · doi:10.3389/fenvs.2025.1573579 · Cited by 98 · see citing works
Recurrent neural networks (RNNs) learn the constitutive law of viscoelasticity
Chen, G. (2021) · Computational Mechanics · doi:10.1007/s00466-021-01981-y · Cited by 90 · see citing works
Influence of artificial intelligence in modern pharmaceutical formulation and drug development
Ali, K. A., Mohin, S., Mondal, P., Goswami, S., Ghosh, S., & Choudhuri, S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00625-1 · Cited by 89 · see citing works
Kausik, A. K., Rashid, A. B., Baki, R. F., & Maktum, M. M. J. (2025) · Array · doi:10.1016/j.array.2025.100393 · Cited by 105 · see citing works
Advances and challenges in deep generative models for de novo molecule generation
Xue, D., Gong, Y., Yang, Z., Chuai, G., Qu, S., Shen, A., Yu, J., & Liu, Q. (2018) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1395 · Cited by 87 · see citing works
DeepScreening: a deep learning-based screening web server for accelerating drug discovery
Liu, Z., Du, J., Fang, J., Yin, Y., Xu, G., & Xie, L. (2019) · Database · doi:10.1093/database/baz104 · Cited by 87 · see citing works
Use of big data in drug development for precision medicine: an update
Qian, T., Zhu, S., & Hoshida, Y. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1617632 · Cited by 85 · see citing works
Artificial intelligence facilitates drug design in the big data era
Wang, L., Ding, J., Pan, L., Cao, D., Jiang, H., & Ding, X. (2019) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2019.103850 · Cited by 80 · see citing works
Accelerating 3D printing of pharmaceutical products using machine learning
Ong, J. J., Muñiz, B., Gaisford, S., Cabalar, P., Basit, A. W., Pérez, G., & Goyanes, Á. (2022) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2022.100120 · Cited by 79 · see citing works
Exploring Tunable Hyperparameters for Deep Neural Networks with Industrial ADME Data Sets
Zhou, Y., Cahya, S., Combs, S. A., Nicolaou, C. A., Wang, J., Desai, P. V., & Shen, J. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00671 · Cited by 78 · see citing works
Lin, F., Cui, E., Yi, L., & Luo, L. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-01992-7 · Cited by 78 · see citing works
Machine learning on adverse drug reactions for pharmacovigilance
Lee, C. Y., & Chen, Y. P. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.003 · Cited by 76 · see citing works
Few-shot classification of ultrasound breast cancer images using meta-learning algorithms
Işık, G., & Paçal, İ. (2024) · Neural Computing and Applications · doi:10.1007/s00521-024-09767-y · Cited by 75 · see citing works
A Deep Learning-Based Chemical System for QSAR Prediction
Hu, S., Chen, P., Gu, P., & Wang, B. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2977009 · Cited by 74 · see citing works
Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches
Das, A. P., & Agarwal, S. M. (2023) · Molecular Diversity · doi:10.1007/s11030-022-10590-7 · Cited by 77 · see citing works
Compound–protein interaction prediction by deep learning: Databases, descriptors and models
Du, B.-X., Qin, Y., Jiang, Y., Xu, Y., Yiu, S., Yu, H., & Shi, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.023 · Cited by 73 · see citing works
The Potential Applications of Artificial Intelligence in Drug Discovery and Development
Farghali, H., Kutinová Canová, N., & Arora, M. (2021) · Physiological Research · doi:10.33549/physiolres.934765 · Cited by 72 · see citing works
Kim, H., Lee, J., Ahn, S., & Lee, J. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90259-7 · Cited by 72 · see citing works
Tripathi, N., Goshisht, M. K., Sahu, S. K., & Arora, C. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10237-z · Cited by 74 · see citing works
Yang, X., Zhang, N., & Schrader, P. T. (2022) · Machine Learning with Applications · doi:10.1016/j.mlwa.2022.100290 · Cited by 70 · see citing works
Ajith, S., Vijayakumar, S., & Elakkiya, N. (2025) · Discover Food · doi:10.1007/s44187-025-00338-1 · Cited by 70 · see citing works
Computational advances in combating colloidal aggregation in drug discovery
Reker, D., Bernardes, G. J. L., & Rodrigues, T. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0234-9 · Cited by 70 · see citing works
Artificial Intelligence in Vaccine and Drug Design
Thomas, S., Abraham, A., Baldwin, J., Piplani, S., & Petrovsky, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1884-4_6 · Cited by 69 · see citing works
Application of artificial intelligence in drug design: A review
Singh, S., Kaur, N., & Gehlot, A. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108810 · Cited by 75 · see citing works
- Authors
- Zhang, L., Tan, J., Han, D., & Zhu, H.
- Affiliations
- Beijing University of Technology (CN)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Tan, Jianjun
- Zhu, Hao
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 22
- Issue
- 11
- Pages
- 1680-1685
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2753588101
- Cited by
- 760
- References
- 60
- Citations by year
- 2026: 42 · 2025: 90 · 2024: 105 · 2023: 134 · 2022: 112 · 2021: 96 · 2020: 79 · 2019: 61 · 2018: 39 · 2017: 2
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chinese Natural Science Foundation Project (21173014)
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- rational drug discovery, deep learning, machine learning, QSAR, big data, history of machine learning, computer-aided drug design
- MeSH terms
- Machine Learning, Artificial Intelligence, Humans, Models, Theoretical, Drug Design, Quantitative Structure-Activity Relationship, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review